These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 3297428)

  • 1. Clinical application of enzyme immunoassay in the analysis of citrullinemia.
    Imamura Y; Kobayashi K; Yamashita T; Saheki T; Ichiki H; Hashida S; Ishikawa E
    Clin Chim Acta; 1987 Apr; 164(2):201-8. PubMed ID: 3297428
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure of an abnormal messenger RNA for argininosuccinate synthetase in citrullinemia.
    Kobayashi K; Ichiki H; Saheki T; Tatsuno M; Uchiyama C; Nukada O; Yoda T
    Hum Genet; 1987 May; 76(1):27-32. PubMed ID: 3570300
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Messenger RNA coding for argininosuccinate synthetase in citrullinemia.
    Kobayashi K; Saheki T; Imamura Y; Noda T; Inoue I; Matuo S; Hagihara S; Nomiyama H; Jinno Y; Shimada K
    Am J Hum Genet; 1986 May; 38(5):667-80. PubMed ID: 3459354
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Citrullinemia: quantitative deficiency of argininosuccinate synthetase in the liver.
    Oyanagi K; Itakura Y; Tsuchiyama A; Nakao T; Nakano K; Saeki T
    Tohoku J Exp Med; 1986 Apr; 148(4):385-91. PubMed ID: 3738904
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pancreatic secretory trypsin inhibitor gene is highly expressed in the liver of adult-onset type II citrullinemia.
    Kobayashi K; Nakata M; Terazono H; Shinsato T; Saheki T
    FEBS Lett; 1995 Sep; 372(1):69-73. PubMed ID: 7556646
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Qualitative and quantitative abnormalities of argininosuccinate synthetase in citrullinemia.
    Saheki T; Ueda A; Hosoya M; Kusumi K; Takada S; Tsuda M; Katsunuma T
    Clin Chim Acta; 1981 Feb; 109(3):325-35. PubMed ID: 6784969
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Argininosuccinate synthetase activity in cultured skin fibroblasts of citrullinemic patients.
    Saheki T; Ueda A; Iizima K; Yamada N; Kobayashi K; Takahashi K; Katsunuma T
    Clin Chim Acta; 1982 Jan; 118(1):93-7. PubMed ID: 7053910
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The heterogeneous distribution of argininosuccinate synthetase in the liver of type II citrullinemic patients. Its specificity and possible clinical implications.
    Yagi Y; Saheki T; Imamura Y; Kobayashi K; Sase M; Nakano K; Matuo S; Inoue I; Hagihara S; Noda T
    Am J Clin Pathol; 1988 Jun; 89(6):735-41. PubMed ID: 3369364
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Variation in argininosuccinate synthetase activity in amniotic fluid cell cultures: implications for prenatal diagnosis of citrullinemia.
    Jacoby LB; Shih VE; Struckmeyer C; Niermeijer MF; Boué J
    Clin Chim Acta; 1981 Oct; 116(1):1-7. PubMed ID: 7318168
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An adult-onset case of argininosuccinate synthetase deficiency presenting with atypical citrullinemia.
    Osafune K; Ichikawa K; Yasui T; Sekikawa A; Takeoka H; Kanatsu K; Kohigashi K; Koshiyama H
    Intern Med; 1999 Jul; 38(7):590-6. PubMed ID: 10435367
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kinetic analysis of argininosuccinate synthetase in a variant form of citrullinaemia.
    Akaboshi I; Endo F; Matsuda I; Saheki T
    J Inherit Metab Dis; 1983; 6(1):36-9. PubMed ID: 6408307
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Qualitative abnormality of liver argininosuccinate synthetase in a patient with citrullinemia.
    Matsuda Y; Tsuji A; Katunuma N
    Adv Exp Med Biol; 1982; 153():77-82. PubMed ID: 7164924
    [No Abstract]   [Full Text] [Related]  

  • 13. A search for the primary abnormality in adult-onset type II citrullinemia.
    Kobayashi K; Shaheen N; Kumashiro R; Tanikawa K; O'Brien WE; Beaudet AL; Saheki T
    Am J Hum Genet; 1993 Nov; 53(5):1024-30. PubMed ID: 8105687
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A case of citrullinemia with cluster type distribution of argininosuccinate synthetase in the liver].
    Ikeda M; Orimo S; Kurosawa T; Arai M; Hiyamuta E
    Rinsho Shinkeigaku; 1987 Jul; 27(7):931-5. PubMed ID: 3665284
    [No Abstract]   [Full Text] [Related]  

  • 15. Argininosuccinate synthetase activity in cultured human lymphocytes.
    Lockridge O; Spector EB; Bloom AD
    Biochem Genet; 1977 Apr; 15(3-4):395-407. PubMed ID: 869901
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of kinetically abnormal argininosuccinate synthase in neonatal citrullinemia by conversion of citrulline to arginine in intact fibroblasts.
    Ben-Yoseph Y; Mitchell DA
    Clin Chim Acta; 1989 Aug; 183(2):125-33. PubMed ID: 2791302
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enzymatic analysis of citrullinemia (12 cases) in Japan.
    Saheki T; Ueda A; Hosoya M; Sase M; Nakano K; Katsunuma T
    Adv Exp Med Biol; 1982; 153():63-76. PubMed ID: 7164923
    [No Abstract]   [Full Text] [Related]  

  • 18. Characterization of human wild-type and mutant argininosuccinate synthetase proteins expressed in bacterial cells.
    Shaheen N; Kobayashi K; Terazono H; Fukushige T; Horiuchi M; Saheki T
    Enzyme Protein; 1994-1995; 48(5-6):251-64. PubMed ID: 8792870
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased urinary excretion of argininosuccinate in type II citrullinemia.
    Saheki T; Kobayashi K; Inoue I; Matuo S; Hagihara S; Noda T
    Clin Chim Acta; 1987 Dec; 170(2-3):297-304. PubMed ID: 3436063
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Generation of a mouse model for citrullinemia by targeted disruption of the argininosuccinate synthetase gene.
    Patejunas G; Bradley A; Beaudet AL; O'Brien WE
    Somat Cell Mol Genet; 1994 Jan; 20(1):55-60. PubMed ID: 8197477
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.